The most commonly reported side effects of obiltoxaximab include congenital diaphragmatic hernia, maternal drugs affecting foetus, and maternal exposure during pregnancy, based on 1 FDA adverse event reports from 2025 to 2025.
Percentages show how often each reaction appears relative to total reports for obiltoxaximab.
These are voluntary reports and do not establish that obiltoxaximab caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
100.0% of obiltoxaximab adverse event reports involve female patients and 0.0% involve male patients. The largest age group is adult at 100%. These figures reflect who reports side effects, not underlying risk.
Sex
Age group
Conditions and purposes for which patients were taking obiltoxaximab when the adverse event was reported.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.